Filgrastim is a type of oncology drug used to treat neutropenia, a condition in which the body does not produce enough white blood cells. It is a recombinant form of human granulocyte colony-stimulating factor (G-CSF), a naturally occurring hormone that stimulates the production of white blood cells. Filgrastim is used to reduce the risk of infection in patients undergoing chemotherapy or bone marrow transplantation. It is also used to treat severe chronic neutropenia, a rare condition in which the body does not produce enough white blood cells. Filgrastim is available in both injectable and subcutaneous forms. The injectable form is administered intravenously, while the subcutaneous form is injected under the skin. Filgrastim is typically administered once a day for five to seven days. Filgrastim is a widely used oncology drug, with many companies producing and marketing it. Some of these companies include Amgen, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
